Pregnant Women at Higher Risk for Influenza-Associated Hospitalization
February 18th 2019Writing in The Journal of Infectious Disease, they noted that pregnant women tend to be treated as high-priority patients when it comes to influenza prevention and treatment, but they said there is relatively little evidence clarifying exactly how outcomes differ for pregnant women versus nonpregnant women.
Read More
Age-Related Macular Degeneration Drug Combo Scrapped Despite Safe Profile
December 11th 2018Zimura (avacincaptad pegol) was generally well tolerated when given to patients in combination with ranibizumab (Lucentis), but Ophthotech Corp announced it will focus efforts on other clinical programs.
Read More
Broadly Neutralizing Antibodies Combination May Suppress HIV Without Antiretroviral Therapy
October 19th 2018A combination of next generation broadly neutralizing antibodies might be able to achieve long-term viral suppression of HIV without the need for a daily antiretroviral pill, according to recently published research.
Read More
Combining Anti-HIV Antibodies May Suppress Virus Without Antiretroviral Therapy
October 18th 2018Broadly neutralizing antibodies have one key advantage over antiretroviral therapy: they have a longer half-life and thus don’t require the daily, lifelong dosing regimen currently required of ART users.
Read More
New Data Show Efficacy of Combo Therapy Elbasvir/Grazoprevir for Hepatitis C
October 3rd 2018A new review of clinical trial data show the combination therapy elbasvir/grazoprevir (EBR/GR) has high rates of efficacy for patients with genotypes 1a, 1b, and 4 chronic hepatitis C (HCV) infection.
Read More
Mobile App Boosts Adherence, Viral Suppression For Patients With HIV
June 28th 2018Researchers at the University of Virginia developed an app called PositiveLinks to test out whether interactive smartphone functions and reminders could have a real-world impact on the health of HIV-positive patients.
Read More